Novavax (NVAX) Misses Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $8.88 -1.66%
Revenue Growth %: -78.2%
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: -78.2%
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q3 EPS of ($0.12), $0.03 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $6.53 million versus the consensus estimate of $10.59 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Carvana (CVNA) PT Lowered to $85 at RBC Capital
- Medtronic completes $550 million Scientia Vascular acquisition
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
